Effect of AYUSH-QOL-II, (Ayurvedic coded drug) in stage III and IV NonSmall Cell Lung Cancer to prevent side effects of Chemotherapy- A PhaseI Ifeasibility & tolerability studY - nil

Central Council For Research in Ayurveda Siddha under department of AYUSH0 个研究点目标入组 40 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Age eligible for study18 years and older
•Gender eligible for studyBoth
•Accept healthy volunteersNo
•Disease characteristicsHistological / Cytological confirmed Non Small Cell Lung Cancer Advanced stage III and IV with measurable lesions (Primary/ metastatic lesions) must be evaluable radio graphically.
•Patient characteristicsOver 18 years of age.
•Performance statusKornoffsky performance status >70%
•Life expectancyat least 3 months after diagnosis
•HepaticPlatelets > 100,000/mm3 S. Bilirubin < 1.5 mg/dl, SGOT and SGPT < 2 times normal
•RenalS. Creatinine < 1.5 mg/dl
•OtherNo concurrent active infection, NO prior malignancy. Not pregnant or nursing, effective contraception required for all female patients.

•Non measurable disease
•Known secondary Neoplasm
•Active Central Nervous System metastasis
•Hermatolymphoid cancers including acute or chronic leukemia, lymphoma or multiple myeloma
•Pregnancy or Breastfeeding or adults of reproductive potential not employing effective birth control measures.
•Concurrent severe or uncontrolled medical disease.
•Acute or chronic liver disease
•Confirmed diagnosis of HIV.
•Insulin dependent diabetes mellitus /abnormal glucose tolerance test (GTT) latent diabetes mellitus type 1 or type
•Surgery less than 4 weeks prior to entry or not recovered from effects of surgery

发起方

Central Council For Research in Ayurveda Siddha under department of AYUSH